Literature DB >> 27943045

The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients.

Brooke Levis1,2, Linda Kwakkenbos1,3,4, Marie Hudson1,5, Murray Baron1,5, Brett D Thombs6,7,8,9,10,11.   

Abstract

Fatigue is prevalent among patients with systemic sclerosis (SSc). To date, studies investigating fatigue in SSc have been hampered by the instruments used to measure fatigue in SSc and have included patient-reported rather than objectively-rated measures of disease. The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale is a validated measure for assessing fatigue in SSc that, compared to other instruments, provides good coverage of the full range of the fatigue spectrum. The objective of this study was to assess sociodemographic and objectively-rated disease-related associates of fatigue, as measured by the FACIT-F, in a large sample of patients with SSc. Fatigue was assessed using the FACIT-F scale. Disease severity was assessed using Medsger's severity scale. Multivariable linear regression was performed to assess the independent associations between sociodemographic and medical variables and fatigue. Among 785 patients, the mean FACIT-F score was 32.2 (SD = 12.1). Being age 40-49 (reference = 60+; standardized regression coefficient (β) = -0.11), less than post-secondary education (β = 0.07), having more medical comorbidities (β = -0.11) and more severe muscle (β = -0.10), gastrointestinal (β = -0.15), lung (β = -0.13), and general system disease severity (β = -0.13) were independently associated with more fatigue (p < 0.05). Fatigue in SSc was independently associated with more severe disease. These data contribute to a better understanding of fatigue in SSc and help inform patient-centered research in SSc.

Entities:  

Keywords:  FACIT-F; Fatigue; Medsger’s disease severity scale; Systemic sclerosis

Mesh:

Year:  2016        PMID: 27943045     DOI: 10.1007/s10067-016-3501-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

1.  What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models.

Authors:  Michael A Babyak
Journal:  Psychosom Med       Date:  2004 May-Jun       Impact factor: 4.312

Review 2.  Psychological health and well-being in systemic sclerosis: State of the science and consensus research agenda.

Authors:  Brett D Thombs; Wim van Lankveld; Marielle Bassel; Murray Baron; Robert Buzza; Shirley Haslam; Jennifer A Haythornthwaite; Marie Hudson; Lisa R Jewett; Ruby Knafo; Linda Kwakkenbos; Vanessa L Malcarne; Katherine Milette; Sarosh J Motivala; Evan G Newton; Warren R Nielson; Marion Pacy; Ilya Razykov; Orit Schieir; Suzanne Taillefer; Maureen Worron-Sauve
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-08       Impact factor: 4.794

3.  Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis.

Authors:  David Cella; Susan Yount; Mark Sorensen; Elliot Chartash; Nishan Sengupta; James Grober
Journal:  J Rheumatol       Date:  2005-05       Impact factor: 4.666

4.  Frequency and impact of disease symptoms experienced by patients with systemic sclerosis from five European countries.

Authors:  L M Willems; L Kwakkenbos; C C Leite; B D Thombs; F H J van den Hoogen; A C Maia; T P M Vliet Vlieland; C H M van den Ende
Journal:  Clin Exp Rheumatol       Date:  2014-11-03       Impact factor: 4.473

5.  Discordance between patient and physician assessments of disease severity in systemic sclerosis.

Authors:  Marie Hudson; Ann Impens; Murray Baron; James R Seibold; Brett D Thombs; Jennifer G Walker; Russell Steele
Journal:  J Rheumatol       Date:  2010-09-15       Impact factor: 4.666

Review 6.  Fatigue in chronic disease.

Authors:  M G Swain
Journal:  Clin Sci (Lond)       Date:  2000-07       Impact factor: 6.124

7.  Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.

Authors:  S B Yellen; D F Cella; K Webster; C Blendowski; E Kaplan
Journal:  J Pain Symptom Manage       Date:  1997-02       Impact factor: 3.612

8.  A disease severity scale for systemic sclerosis: development and testing.

Authors:  T A Medsger; A J Silman; V D Steen; C M Black; A Akesson; P A Bacon; C A Harris; S Jablonska; M I Jayson; S A Jimenez; T Krieg; E C Leroy; P J Maddison; M L Russell; R K Schachter; F A Wollheim; H Zacharaie
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

9.  Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis.

Authors:  Brett D Thombs; Marie Hudson; Suzanne S Taillefer; Murray Baron
Journal:  Arthritis Rheum       Date:  2008-04-15

10.  The comparability of English, French and Dutch scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): an assessment of differential item functioning in patients with systemic sclerosis.

Authors:  Linda Kwakkenbos; Linda M Willems; Murray Baron; Marie Hudson; David Cella; Cornelia H M van den Ende; Brett D Thombs
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

View more
  1 in total

1.  Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry.

Authors:  Victoria K Shanmugam; Tracy M Frech; Virginia D Steen; Laura K Hummers; Ami A Shah; Elana J Bernstein; Dinesh Khanna; Jessica K Gordon; Flavia V Castelino; Lorinda Chung; Faye N Hant; Emily Startup; John M VanBuren; Luke B Evnin; Shervin Assassi
Journal:  Clin Rheumatol       Date:  2019-10-30       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.